Back to results
US 2009/0156468 A1Published application
Use of human chorionic gonadotropin oral or injectable for metabolic syndrome treatment
AssigneeDr. Daniel Oscar Belluscio
InventorDaniel Oscar Belluscio
Life of this patent
Estimating the term…
Abstract
To be used as a therapy for patients with one or more of the following clinical symptoms or laboratory findings: high blood pressure, diabetes type 2, reactive hyperglycemia, plasmatic hypertriglyceridemia, hypercholesterolemia and gout as part of the metabolic syndrome.
Claims8
THE USE OF HUMAN CHORIONIC GONADOTROPIN ORAL OR INJECTABLE FOR THE TREATMENT OF METABOLIC SYNDROME characterized by administration of Human Chorionic Gonadotropin (hCG) in patients with Metabolic Syndrome, in a range of 300-600 International Units daily by oral route, or 100-300 International Units daily by injection during the treatment period.
Dependencies are inferred from the claim text.